Connection

KENNETH R HESS to Phosphatidylinositol 3-Kinases

This is a "connection" page, showing publications KENNETH R HESS has written about Phosphatidylinositol 3-Kinases.
  1. Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells. J Transl Med. 2016 Feb 09; 14:46.
    View in: PubMed
    Score: 0.021
  2. Outcomes of patients with advanced cancer and KRAS mutations in phase I clinical trials. Oncotarget. 2014 Oct 15; 5(19):8937-46.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.